Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06872723 · ClinicalTrials.gov registry record

CPRIT: Patient Adherence to Lung Cancer Screening

A clinical trial of Lung Cancer Screening, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
340
Enrollment target
1
Study location

NCT06872723: Recruiting study of Lung Cancer Screening, sponsored by M.D. Anderson Cancer Center.

NCT06872723 is a study of Lung Cancer Screening that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 340 participants, below the 481-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06872723, a study of Lung Cancer Screening, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
340 participants
Enrollment target
1
Study location

Study Summary

To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

Conditions Studied

Interventions

  • BEHAVIORAL Lung Cancer Screening

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2025-03-21
Est. Completion 2031-02-28
M.D. Anderson Cancer Center

2,692 total trials

What NCT06872723 shows while recruiting

NCT06872723 is an observational study that tracks outcomes without assigning an intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (29% lower).

The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Lung Cancer Screening is the first listed.

NCT06872723 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06872723 about?

NCT06872723 is a clinical study titled "CPRIT: Patient Adherence to Lung Cancer Screening". To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

What is the current status of trial NCT06872723?

This trial is currently recruiting. The enrollment target is 340 participants. The study started on 2025-03-21. Estimated completion is 2031-02-28.

What conditions does trial NCT06872723 study?

This clinical trial studies the following conditions: Lung Cancer Screening.

What interventions are being tested in trial NCT06872723?

The interventions under investigation include: Lung Cancer Screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT06872723?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06872723 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

  • NCT04806958 · 340 participants · NA

    The PulsePoint Study

  • NCT05323409 · 340 participants · NA

    Improving Comprehensive Care of Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06872723, the US trial registry maintained by the National Library of Medicine. NCT06872723 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.